日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Androgen Receptor-Controlled microRNA-124-3p.2 Suppresses Prostate Cancer Progression via CCL2 Inhibition

雄激素受体调控的microRNA-124-3p.2通过抑制CCL2抑制前列腺癌进展

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70157
Aoyama, Shuhei; Izumi, Kouji; Hiratsuka, Kaoru; Inaba, Takahiro; Koketsu, Yoshiki; Nakagawa, Ryunosuke; Toriumi, Ren; Kamijima, Taiki; Kano, Hiroshi; Makino, Tomoyuki; Naito, Renato; Kadomoto, Suguru; Iwamoto, Hiroaki; Yaegashi, Hiroshi; Kawaguchi, Shohei; Shigehara, Kazuyoshi; Nohara, Takahiro; Nakata, Hiroki; Saito, Yohei; Nakagawa-Goto, Kyoko; Lin, Wen-Jye; Mizokami, Atsushi
肿瘤
肿瘤免疫
CCL2
信号转导
前列腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Bone Turnover Markers, n-Terminal Propeptide of Type I Procollagen and Tartrate-Resistant Acid Phosphatase Type 5b, for Predicting Castration Resistance in Prostate Cancer

骨转换标志物、I型前胶原N端前肽和抗酒石酸酸性磷酸酶5b型，用于预测前列腺癌去势抵抗性

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines12020292
Kano, Hiroshi; Izumi, Kouji; Nakagawa, Ryunosuke; Toriumi, Ren; Aoyama, Shuhei; Kamijima, Taiki; Makino, Tomoyuki; Naito, Renato; Iwamoto, Hiroaki; Yaegashi, Hiroshi; Kawaguchi, Shohei; Shigehara, Kazuyoshi; Nohara, Takahiro; Mizokami, Atsushi
肿瘤
前列腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

Decreased febrile neutropenia during inpatient chemotherapy for urologic cancer during coronavirus disease 2019 pandemic

2019冠状病毒病大流行期间，泌尿系统癌症住院化疗期间发热性中性粒细胞减少症发生率降低

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15490
Toriumi, Ren; Yaegashi, Hiroshi; Kadomoto, Suguru; Iwamoto, Hiroaki; Iijima, Masashi; Kawaguchi, Shohei; Nohara, Takahiro; Shigehara, Kazuyoshi; Izumi, Kouji; Kadono, Yoshifumi; Mizokami, Atsushi
肿瘤
中性粒细胞
肿瘤免疫
粒细胞
微生物学
细胞生物学
发表日期：2023
文献求助 收藏

Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate Cancer.

血清 CCL2 是非转移性去势敏感性前列腺癌的预后生物标志物

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines10102369
Iwamoto Hiroaki, Izumi Kouji, Nakagawa Ryunosuke, Toriumi Ren, Aoyama Shuhei, Kamijima Taiki, Shimada Takafumi, Kano Hiroshi, Makino Tomoyuki, Naito Renato, Kadomoto Suguru, Yaegashi Hiroshi, Kawaguchi Shohei, Nohara Takahiro, Shigehara Kazuyoshi, Kadono Yoshifumi, Mizokami Atsushi
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Long response duration to pembrolizumab in metastatic, castration-resistant prostate cancer with microsatellite instability-high and neuroendocrine differentiation: A case report

帕博利珠单抗治疗转移性去势抵抗性前列腺癌伴微卫星不稳定性高和神经内分泌分化，疗效持续时间长：病例报告

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.912490
Yoshida, Tsukasa; Yaegashi, Hiroshi; Toriumi, Ren; Kadomoto, Suguru; Iwamoto, Hiroaki; Izumi, Kouji; Kadono, Yoshifumi; Ikeda, Hiroko; Mizokami, Atsushi
肿瘤
前列腺癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Ischemic proctitis after low-dose-rate brachytherapy using hydrogel spacer for prostate cancer

前列腺癌低剂量率近距离放射治疗联合水凝胶间隔器治疗后发生缺血性直肠炎

期刊:IJU Case Reports
影响因子:0.6
doi:10.1002/iju5.12444
Toriumi, Ren; Yaegashi, Hiroshi; Sakurai, Takayuki; Takamatsu, Shigeyuki; Shigehara, Kazuyoshi; Izumi, Kouji; Kadono, Yoshifumi; Mizokami, Atsushi
肿瘤
前列腺癌
肠炎
肿瘤免疫
发表日期：2022
文献求助 收藏